×
0.000577617328519946 0.000577617328519946 0.000144404332130038 -0.00187725631768947 -0.00707581227436816 0.0020216606498195 0.0020216606498195 0.0020216606498195
Stockreport

Biotech Sinks As Debate Weighs On Cancer Treatment Rivalry [Investor's Business Daily]

BLUEPRINT MEDICINES CORP COMMON (BPMC)  More Company Research Source: Investors Business Daily
Last blueprint medicines corp common earnings: 10/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: blueprintmedicines.com
PDF Related news Blueprint Medicines ( BPMC ) sank to a two-month low Monday as investors compared its thyroid cancer treatment to a rival therapy from Loxo Oncology ( LOXO ). In afternoon trading on the stock market today , Blueprint stock toppled 2.7%, near 67.70. Loxo stock, on the other hand, rose a fraction, near 160.50. Both biotech companies unveiled data from studies of their thyroid cancer treatments on Saturday. The biotech companies are working on cancer treatments for patients with aberrations in the RET gene . Blueprint's cancer treatment had a 49% overall response rate across all medullary thyroid cancer patients. That seemingly trailed better responses for Loxo's drug. But Raymond James analyst Laura Chico kept her outperform rating on Blueprint stock. She noted there are differences in the biotech companies' studies, including cutoff date. Blueprint's data is current as of September, whereas Loxo is current as of July. "Bottom line, we think (effectiveness) may not be tha [Read more]

IMPACT SNAPSHOT EVENT TIME: BPMC
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
BPMC alerts
from News Quantified
Opt-in for
BPMC alerts

from News Quantified
Opt-in for
BPMC alerts

from News Quantified